Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 72 clinical trials
Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19

Randomized, double-blinded, placebo-controlled trial comparing oral anticoagulation with placebo for community-dwelling patients with symptomatic COVID-19 infection and risk factors for thrombosis.

  • 0 views
  • 25 Mar, 2021
  • 4 locations
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism

Design: U.S.-based, single-center, randomized placebo-controlled trial. Brief Treatment Description: Low-intensity apixaban (2.5mg twice daily) for extended-duration secondary prevention

inflammatory bowel disease
dvts
asthma
COPD
pulmonary embolism
  • 0 views
  • 11 Jul, 2021
  • 1 location
Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

This study aims to determine if treatment with apixaban, compared with aspirin, will reduce the risk of ischemic stroke and systemic embolism in patients with device-detected sub-clinical atrial

diabetes
hypertension
vascular disease
cardiac monitoring
stroke
  • 337 views
  • 26 Jan, 2021
  • 132 locations
Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Apixaban and rivaroxaban have been compared to standard therapy for treatment of acute symptomatic venous thromboembolism (VTE) in randomized controlled trials (RCTs), and are both approved by

apixaban
rivaroxaban
anticoagulants
probe
venous thromboembolism
  • 285 views
  • 29 Jan, 2021
  • 21 locations
PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban

aortic valve can be maintained safely and effectively on apixaban. Both the On-X aortic valve and apixaban have been approved for use by the US Food and Drug Administration (FDA) but they have not been

apixaban 5 mg
warfarin
aspirin
  • 79 views
  • 04 Aug, 2021
  • 75 locations
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

Objectives Primary: To test the hypothesis that apixaban is superior to aspirin for the prevention of recurrent stroke in patients with cryptogenic ischemic stroke and atrial

infarct
heart disease
aspirin
ischemic stroke
recurrent strokes
  • 378 views
  • 26 Jan, 2021
  • 175 locations
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH

vascular disease
electrocardiogram
stroke
fibrillation
antiplatelet agents
  • 84 views
  • 04 Aug, 2021
  • 104 locations
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation

comparing efficacy and safety of the four NOACs, edoxaban, apixaban, rivaroxaban and dabigatran for oral anticoagulation in non-valvular atrial fibrillation across Danish hospitals and cardiology clinics

vitamin k antagonist
noac
anticoagulants
anticoagulation therapy
edoxaban
  • 35 views
  • 22 Jan, 2021
  • 25 locations
REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism.

conventional dose warfarin (INR 2-3). Low dose of DOAC has the potential to validate this hypothesis. In a first randomized trial comparing full-dose or low-dose apixaban with a placebo during an

warfarin
apixaban 2.5 mg
aspirin
apixaban
anticoagulants
  • 7 views
  • 27 Jan, 2021
  • 59 locations
Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants

with moderate and severe renal insufficiency. We plan to evaluate reduced doses of 2 DOAs (apixaban, rivaroxaban) compared to SOC in VTE patients with moderate or severe renal insufficiency in

anticoagulant
heparin
anticoagulants
vitamin k antagonists
renal function
  • 5 views
  • 26 Jan, 2021
  • 39 locations